ASGCT POAG Presentation

Oct

14

Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference

Oct

8

Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia

Sep

9

Editas Medicine Reports Inducement Grants to New Chief Medical Officer